Hosted on MSN1h
Henry Schein extends gain on report of activist stake, push for board changes
A sale of the medical distribution business could increase Henry Schein's (HSIC) shares by 20%, while EPS could jump by ~35% ...
UBS: Henry Schein, Inc. (NASDAQ:HSIC) Is A Bottom-Ranked Quant Stock
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, ...
Henry Schein’s Sell Rating: Internal Sales Weakness and Valuation Concerns Amidst Cybersecurity and Market Challenges
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...
Henry Schein Updates 2024 Financial Guidance Amid Solid Q3
Henry Schein ( (HSIC) ) has released its Q3 earnings. Here is a breakdown of the information Henry Schein presented to its investors. Henry ...
Henry Schein 3Q Net Income Down, Raises Lower End of 2024 Adj EPS View
The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...